Medicus Pharma Ltd. Common Stock (MDCX) vs NeuroOne Medical Technologies Corporation (NMTC)
A side-by-side comparison of Medicus Pharma Ltd. Common Stock and NeuroOne Medical Technologies Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MDCX
Medicus Pharma Ltd. Common Stock
$0.16HealthcareDelayed quote: Oct 6, 2026, 1:29 PM EDT
NMTC
NeuroOne Medical Technologies Corporation
$1.10HealthcareDelayed quote: Oct 6, 2026, 1:25 PM EDT
Total return — MDCX vs NMTC
growth of $100 · dividends reinvested · last 2yMDCX -93.7% (-74.9%/yr)NMTC -76.1% (-51.1%/yr)NMTC compounded faster over this window
MDCX NMTC
MDCX vs NMTC: by the numbers
- •MDCX is the larger company ($10M vs $10M market cap).
- •Both run net losses; MDCX's is the smaller (0.00% vs -71.51% net margin).
Metrics side by side
Valuation
| Metric | MDCX | NMTC |
|---|---|---|
| P/S ratio | N/A | 0.96 |
| P/B ratio | N/A | 2.54 |
Profitability
| Metric | MDCX | NMTC |
|---|---|---|
| Gross margin | 0.00% | 67.30% |
| Operating margin | 0.00% | -34.94% |
| Net margin | 0.00% | -71.51% |
| ROE | N/A | -189.76% |
| ROIC | -269.16% | -183.45% |
Growth (annualized)
| Metric | MDCX | NMTC |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 37.21% |
| Total return CAGR (5Y) | N/A | -46.02% |
Go deeper
Dig into the metrics
Medicus Pharma Ltd. Common Stock ROENeuroOne Medical Technologies ROEMedicus Pharma Ltd. Common Stock operating marginNeuroOne Medical Technologies operating marginMedicus Pharma Ltd. Common Stock revenue growthNeuroOne Medical Technologies revenue growthMedicus Pharma Ltd. Common Stock free cash flowNeuroOne Medical Technologies free cash flow
Medicus Pharma Ltd. Common Stock & NeuroOne Medical Technologies appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.